Prosecution Insights
Last updated: July 17, 2026
Application No. 18/550,846

Polyol and a Process for the Preparation Thereof

Non-Final OA §103
Filed
Sep 15, 2023
Priority
Mar 19, 2021 — provisional 63/163,191 +2 more
Examiner
COPENHEAVER, BLAINE R
Art Unit
1781
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF SE
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
45 granted / 54 resolved
+18.3% vs TC avg
Strong +20% interview lift
Without
With
+19.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
40 currently pending
Career history
93
Total Applications
across all art units

Statute-Specific Performance

§103
73.9%
+33.9% vs TC avg
§102
4.9%
-35.1% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 54 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I (claims 66-68) in the reply filed on May 20, 2026 is acknowledged. The traversal is on the grounds that the inventions are linked by special technical features not disclosed in DE ‘120. This is not found persuasive because, as set forth in the below prior art rejection over DE ‘120, the common technical features do not made a contribution over the prior art as required for unity of invention under PCT Rule 13.2. The requirement is still deemed proper and is therefore made FINAL. Claims 69-85 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 66-68 are rejected under 35 U.S.C. 103 as being unpatentable over DE 43 18 120. The English language translation submitted in the IDS filed on May 24, 2024 is relied on in this Office action. Regarding claim 66, DE ‘120 discloses a polyalkyleneoxy polyol ([0016], [0027]) having an average nominal functionality of 2-4 [0027], a hydroxy number of 30 to 60 mg KOH/g [0016], an average molecular weight of 2200 to 6500 [0027], and an ethyleneoxy amount in the range of 60-90 wt% of the polyol [0016]. DE ‘120 discloses that the primary hydroxy content is in the range of >50% [0027], which overlaps with the presently claimed range of 30 to 65%. As set forth in MPEP 2144.05, “In the case where the claimed ranges ‘overlap or lie inside ranges disclosed by the prior art’ a prima facie case of obviousness exists.” In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976). Further, DE ‘120 discloses that the primary hydroxy content is a result effective variable based on the amount of closed cells present in a foam formed with the polyol [0051]. Regarding claim 67, DE ‘120 discloses that the polyol can further contain propyleneoxy ([0016], [0027]). Regarding claim 68, DE ‘120 discloses a viscosity within the presently claimed range (Examples 1 and 2). Claims 66-68 are rejected under 35 U.S.C. 103 as being unpatentable over Pluracol® 593 Technical Bulletin (hereinafter “Pluracol”) as evidenced by Neff (US Pub 2004/0266900) in view of either DE 43 18 120 or Reisch et al. (US Patent No. 4,946,922). Regarding claim 66, Pluracol discloses a polyalkyleneoxy polyol having an average nominal functionality of 3, a hydroxy number of 44.0-47.0 mg KOH/g and an average molecular weight of 3650. As evidenced by Neff, Pluracol® 593 has an ethyleneoxy content of 75% [0043]. Pluracol is silent as to the primary hydroxy content of the polyol. As stated above, DE ‘120 discloses a primary hydroxy content of >50% and discloses that the primary hydroxy content is a result effective variable based on the amount of closed cells present in a foam formed with the polyol [0051]. Additionally, Reisch discloses that the content of primary hydroxyl is a result effective variable based on the miscibility properties of a blended polyol and the mold release properties desired (column 4, lines 22-57). It would have been obvious to one of ordinary skill in the art to have formed the polyol of Pluracol, wherein the primary hydroxy content is within the claimed range of 30-65%, motivated by the desire to optimize or discover workable ranges based on the amount of closed cells desired in a resulting foam product formed with the polyol, as taught in DE ‘120, and/or the miscibility and mold release properties desired, as taught in Reisch. Regarding claim 67, as evidenced by Neff, Pluracol® 593 has a propyleneoxy content of 25% [0043]. Regarding claim 68, Pluracol has a viscosity of 1340 at 25ᵒC. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Blaine Copenheaver whose telephone number is (571)272-1156. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Frank Vineis can be reached at (571)270-1547. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BLAINE COPENHEAVER/Primary Examiner, Art Unit 1781
Read full office action

Prosecution Timeline

Sep 15, 2023
Application Filed
Jul 02, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679078
LAMINATED FILM AND BAG
2y 10m to grant Granted Jul 14, 2026
Patent 12668528
GLASS ARTICLE
3y 4m to grant Granted Jun 30, 2026
Patent 12668047
PLASTIC FILM, PLASTIC BAG AND PREPARATION METHOD OF PLASTIC FILM
3y 0m to grant Granted Jun 30, 2026
Patent 12668729
PROTECTIVE COLLOID WITH EFFECTIVE PROTECTION OF ATTACHMENT AND METHOD FOR USING THE SAME
2y 11m to grant Granted Jun 30, 2026
Patent 12662608
Waterborne Coating Composition
2y 10m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+19.5%)
2y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 54 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month